glp-1 agonists herbs Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 drugs are everywhere right

While BP reduction is not their primary indication, GLP-1 RAs are increasingly prescribed to patients with T2DM, obesity, and metabolic syndrome, which are populations in which hypertension is common and often difficult to control

We currently have dulaglutide, liraglutide and sc semaglutide with approved CV indication (see Table 1)

It is essential to emphasise that patients with significant dyslipidaemia requiring substantial LDL cholesterol reduction should receive appropriate lipid-lowering therapy according to NICE guideline NG238

Many patients describe less preoccupation with food, fewer cravings, and less urgency around eating

[cited 2023 Apr 24]